
Bio-Sourcing and Zerion Pharma have obtained a €1.3 million EU grant reward under the Eurostars program to advance an orally administered anti‑HER2 antibody Trastuzimab, for treatment of breast cancer. tinyurl.com/2dfpcpba

English
BioWin
2.9K posts

@BioWin_asbl
Accelerating Belgian health-tech & biopharma innovation
































